OTCMKTS:ARDMQ

Aradigm Stock Forecast, Price & News

$0.05
0.00 (0.00 %)
(As of 06/30/2020)
Add
Compare
Today's Range
$0.05
Now: $0.05
$0.05
50-Day Range
$0.05
MA: $0.05
$0.05
52-Week Range
$0.02
Now: $0.05
$0.20
VolumeN/A
Average Volume21,923 shs
Market Capitalization$764,000.00
P/E RatioN/A
Dividend YieldN/A
Beta2.91
Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ARDMQ
CUSIPN/A
CIKN/A
Phone510-265-9000
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$764,000.00
Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1972nd out of 2,019 stocks

Electromedical Equipment Industry

61st out of 61 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.05
0.00 (0.00 %)
(As of 06/30/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive ARDMQ News and Ratings via Email

Sign-up to receive the latest news and ratings for ARDMQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aradigm (OTCMKTS:ARDMQ) Frequently Asked Questions

What stocks does MarketBeat like better than Aradigm?

Wall Street analysts have given Aradigm a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aradigm wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Aradigm's key competitors?

What is Aradigm's stock symbol?

Aradigm trades on the OTCMKTS under the ticker symbol "ARDMQ."

How do I buy shares of Aradigm?

Shares of ARDMQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aradigm's stock price today?

One share of ARDMQ stock can currently be purchased for approximately $0.05.

How much money does Aradigm make?

Aradigm has a market capitalization of $764,000.00.

What is Aradigm's official website?

The official website for Aradigm is www.aradigm.com.

Where are Aradigm's headquarters?

Aradigm is headquartered at 3929 POINT EDEN WAY, HAYWARD CA, 94545.

How can I contact Aradigm?

Aradigm's mailing address is 3929 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-265-9000 or via email at [email protected]


This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.